搜索临床试验以:其他治疗组合
总计31694个结果
-
Instituto Dante Pazzanese de Cardiologia完全的
-
Rete Oncologica Piemonte, Valle d'AostaAzienda Ospedaliera Città della Salute e della Scienza di Torino; Compagnia di San Paolo完全的
-
State University of MaringáFundação de Amparo à Pesquisa do Estado do Amazonas未知
-
University Hospitals Cleveland Medical CenterBioMarin Pharmaceutical完全的
-
Asker & Baerum HospitalSahlgrenska University Hospital, Sweden; Rikshospitalet University Hospital; University Hospital...完全的
-
Groupe Hospitalier Paris Saint Joseph完全的
-
Nova Scotia Health Authority完全的
-
Heilongjiang University of Chinese MedicineThe University of Hong Kong; Yale University; Jiangsu Province Hospital of Traditional Chinese... 和其他合作者完全的
-
University of Alabama at BirminghamUltragenyx Pharmaceutical Inc完全的
-
Brainsway完全的重度抑郁症,复发性,未明确 | 重度抑郁症,单次发作,未指定美国, 加拿大, 德国, 以色列
-
Commonwealth Scientific and Industrial Research...Agency for Science, Technology and Research未知
-
Sixth Affiliated Hospital, Sun Yat-sen University招聘中
-
Harvard University Faculty of MedicineBrigham and Women's Hospital; Palmer Center for Chiropractic Research (PCCR)完全的
-
Fuda Cancer Hospital, Guangzhou完全的
-
University Hospital, Bordeaux招聘中在使用 PD1/PDL1 ICIs + VEGFR-酪氨酸激酶抑制剂治疗 12 个月时有客观反应的 mRCC 患者中只有一个不良预后因素的 IMDC 良好或中等风险的治疗暂停与治疗继续 (SPICI)转移性肾细胞癌 | 每个 IMDC 评分的良好或只有一个不良预后因素中等风险法国